CETP, Control Peptide (Cholesteryl Ester Transfer Protein)
Catalog No : USB-C3050A
348.29€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | CETP, Control Peptide (Cholesteryl Ester Transfer Protein) | ||
|---|---|---|---|
| Catalog No | USB-C3050A | ||
| Supplier’s Catalog No | C3050A | ||
| Supplier | US Biologicals | ||
| Source antigen | |||
| Reactivity | Immunizing peptide corresponds to the C-terminal amino acid residues 140-151 of human CETP protein, C(140)DSGRVRTDAPD(151). Corresponds to anti-CETP C3050 which detects cholesteryl ester transfer protein (CETP) from human tissues. | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | 4°C (-20°C Glycerol) | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified | ||
| Form | Supplied as a lyophilized powder. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified | ||
| Description | It has been proposed that high density lipoproteins (HDLs) function jointly with lecithin:cholesterol acyltransferase and CETP to facilitate cholesterol transport from tissues to the liver. This mechanism, referred to as reverse cholesterol transport, is physiologically important because it maintains systemic cholesterol levels. CETP is responsible for neutral lipid transfer activity in plasma in numerous species. Since CETP is able to specifically accelerate the exchange of lipid components between pro- and anti-atherogenic lipoprotein fractions, it may be a key determinant of the global atherogenicity of the plasma lipoprotein profile and arises as a possible target in atherosclerosis prevention. In general, elevated levels of CETP have been associated with increased risk of coronary heart disease. Applications: Suitable for use in ELISA, Western Blotting neutralization and control experiments. Other applications not tested. Recommended Dilution: Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~70-fold) for competitive inhibition of antibody-protein binding reactions. Optimal dilutions to be determined by the researcher. Reconstitution: Reconstitute with 0.1ml of distilled water. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved